Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?

Journal of Surgical Research

Volumn 200, Issue 1, 2015, Pages 122-130

  Huang, Jiwei ^a   Yan, Lunan ^a   Wu, Hong ^a   Yang, Jiayin ^a   Liao, Mingheng ^a   Zeng, Yong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Liver transplantation; Radiofrequency ablation; Recurrence; Survival

Indexed keywords

ANALGESIC AGENT; RAPAMYCIN; SORAFENIB;

ADULT; ANASTOMOSIS; ANEMIA; ARTICLE; ASCITES; BILIOENTERIC ANASTOMOSIS; BLOOD TRANSFUSION; CADAVER DONOR; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHILD PUGH SCORE; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DECEASED DONOR LIVER TRANSPLANTATION; DIGESTIVE SYSTEM DISEASE ASSESSMENT; FEMALE; HEMORRHAGIC ANEMIA; HUMAN; JAUNDICE; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FAILURE; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; MILAN CRITERIA; MULTIPLE CANCER; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RERECURRENCE FREE SURVIVAL; SYSTEMIC THERAPY; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; EVALUATION STUDY; FOLLOW UP; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; REOPERATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REOPERATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84939863222     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.07.033     Document Type: Article

References (33)

1. V. Mazzaferro, E. Regalia, R. Doci, and et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693
2. J.M. Llovet, J. Fuster, and J. Bruix Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1999 1434
3. S. Iwatsuki, T.E. Starzl, D.G. Sheahan, and et al. Hepatic resection versus transplantation for hepatocellular carcinoma Ann Surg 214 1991 228
4. T. Tanaka, Y. Sugawara, and N. Kokudo The current clinical aspects of idiopathic portal hypertension Intractable Rare Dis Res 2 2013 94
5. S. Roayaie, J.D. Schwartz, M.W. Sung, and et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis Liver Transpl 10 2004 534
6. H.J. Schlitt, M. Neipp, A. Weimann, and et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation J Clin Oncol 17 1999 324
7. M. Cescon, M. Ravaioli, G.L. Grazi, and et al. Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma J Transpl 2010 2010 904152
8. A. Escartin, G. Sapisochin, I. Bilbao, and et al. Recurrence of hepatocellular carcinoma after liver transplantation Transplant Proc 39 2007 2308
9. A. Valdivieso, J. Bustamante, M. Gastaca, and et al. Management of hepatocellular carcinoma recurrence after liver transplantation Transplant Proc 42 2010 660
10. E. Regalia, L.R. Fassati, U. Valente, and et al. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation J Hepatobiliary Pancreat Surg 5 1998 29
11. A. Kornberg, B. Küpper, A. Tannapfel, and et al. Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables Eur J Surg Oncol 36 2010 275
12. M. Minagawa, M. Makuuchi, T. Takayama, and N. Kokudo Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma Ann Surg 238 2003 703
13. S. Arii, K. Monden, M. Niwano, and et al. Results of surgical treatment for recurrent hepatocellular carcinoma: comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence J Hep Bil Pancr Surg 5 1998 86
14. M. Shimada, K. Takenaka, T. Gion, and et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan Gastroenterology 111 1996 720
15. M.S. Chen, J.Q. Li, Y. Zheng, and et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma Ann Surg 243 2006 321
16. J. Huang, R. Hernandez-Alejandro, K.P. Croome, and et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics - a retrospective study of 1,061 cases J Gastrointest Surg 15 2011 311
17. R. Guo, X.B. Feng, S.L. Xiao, and et al. Short- and long-term outcomes of hepatectomy with or without radiofrequency-assist for the treatment of hepatocellular carcinomas: a retrospective comparative cohort study Biosci Trends 9 2015 65
18. T. Iguchi, D. Inoue, K. Yabushita, and et al. Effect of CT fluoroscopy-guided transpulmonary radiofrequency ablation of liver tumours on the lung Br J Radiol 85 2012 e373
19. T. Hiraki, H. Gobara, H. Mimura, and et al. Long-term survival after radiofrequency ablation for pulmonary metastasis from hepatocellular carcinoma: report of two cases J Vasc Interv Radiol 20 2009 1106
20. F.Y. Yao Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria Am J Transplant 8 2008 1982
21. J. Li, L.N. Yan, J. Yang, and et al. Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients World J Gastroenterol 15 2009 4170
22. J.W. Marsh, I. Dvorchik, C.A. Bonham, and S. Iwatsuki Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 88 2000 538
23. J. Huang, L. Yan, Z. Cheng, and et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria Ann Surg 252 2010 903
24. J. Bruix, M. Sherman, J.M. Llovet, and et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona 2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421
25. V. Mazzaferro, J.M. Llovet, R. Miceli, and et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 2009 35
26. V. Mazzaferro, S. Bhoori, C. Sposito, and et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience Liver Transpl 17 Suppl 2 2011 S44
27. J. Kaneko, Y. Sugawara, T. Yamaguchi, and et al. Telaprevir-based triple therapy for hepatitis C null responders among living donor liver transplant recipients Biosci Trends 8 2014 339
28. N. Akamatsu, Y. Sugawara, and N. Kokudo Acute liver failure and liver transplantation Intractable Rare Dis Res 2 2013 77
29. E. Davis, R. Wiesner, J. Valdecasas, Y. Kita, M. Rossi, and M. Schwartz Treatment of recurrent hepatocellular carcinoma after liver transplantation Liver Transpl 17 Suppl 2 2011 Oct S162
30. A. Taketomi, T. Fukuhara, K. Morita, and et al. Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation Ann Surg Oncol 17 2010 2283
31. A.P. Monaco The role of mTOR inhibitors in the management of post-transplant malignancy Transplantation 87 2009 157
32. J.M. Llovet, S. Ricci, V. Mazzaferro, and et al. Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378
33. Y. Wang, K.V. Speeg, W.K. Washburn, and G. Halff Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: a case report World J Gastroenterol 16 2010 5518